Growth inhibiton of human breast cancer cell line MDA-MB-231 by rosiglitazone through activation of PPARγ

Objective To investigate the anti-proliferative effect of rosiglitazone and its relationship to peroxisome proliferator-activated receptor γ (PPARγ) in human breast cancer cell line MDA-MB-231 and evaluate the potential application value of rosiglitazone for breast cancer therapy.